Leila Farahmand
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 5%
- Immunology top 10%
- Biomedical Engineering
- Co-authors
- Keivan Majidzadeh‐AShima Moradi‐KalbolandiBehrad DarvishiKhadijeh BarzamanMohammad Hossein KazemiElahe SafariJafar KaramiZeinab Zarei‐Behjani
- Topics
- Monoclonal and Polyclonal Antibodies Research (18 papers)Cancer Cells and Metastasis (13 papers)Glycosylation and Glycoproteins Research (11 papers)
- Partner nations
- IranUnited StatesCanada
In The Last Decade
Leila Farahmand
73 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Molecular Biology 849
- Oncology 552
- Cancer Research 404
- Immunology 238
- Biomedical Engineering 218
Countries citing papers authored by Leila Farahmand
This map shows the geographic impact of Leila Farahmand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila Farahmand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila Farahmand more than expected).
Fields of papers citing papers by Leila Farahmand
This network shows the impact of papers produced by Leila Farahmand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila Farahmand. The network helps show where Leila Farahmand may publish in the future.
Co-authorship network of co-authors of Leila Farahmand
This figure shows the co-authorship network connecting the top 25 collaborators of Leila Farahmand. A scholar is included among the top collaborators of Leila Farahmand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leila Farahmand. Leila Farahmand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 6 | |
| 4 | 23 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 35 | |
| 9 | 11 | |
| 10 | 13 | |
| 11 | 5 | |
| 12 | 6 | |
| 13 | 5 | |
| 14 | 32 | |
| 15 | 33 | |
| 16 | 10 | |
| 17 | 15 | |
| 18 | 44 | |
| 19 | 8 | |
| 20 | Ligation Independent Cloning of Polycistronic, Genetically Modified, HuMAb4D5-8 F (ab`)2, in Bacterial Plasmid | 1 |
About Leila Farahmand
Leila Farahmand is a scholar working on Biophysics, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 74 papers that have together received 1.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (18 papers), Cancer Cells and Metastasis (13 papers) and Glycosylation and Glycoproteins Research (11 papers). The work is most often cited by research in Cancer Research (404 citations), Oncology (552 citations) and Molecular Biology (849 citations). Leila Farahmand has collaborated with scholars based in Iran, United States and Canada. Frequent co-authors include Keivan Majidzadeh‐A, Shima Moradi‐Kalbolandi, Behrad Darvishi, Khadijeh Barzaman, Mohammad Hossein Kazemi, Elahe Safari, Jafar Karami, Zeinab Zarei‐Behjani, Mohammad Zarei and Zahra Eslami‐S. Their work appears in journals such as Nature Communications, Free Radical Biology and Medicine and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.